Table 1.

Patient characteristics (N = 97).

Patient characteristics	Data
Treating institution (no. of patients)
Massachusetts General Hospital	49
Dana-Farber Cancer Institute / Brigham and Women's Hospital	48
Neoadjuvant chemotherapy*	1
Neoadjuvant radiotherapy	0
Pre-operative MDR-CT scan available	87 (90%)
Pre-operative EUS available	46 (47%)
Median days between MDR-CT and surgery	19 (range, 0-90)
Median age at surgery (y)	63
Year of surgery	2001-2009

Abbreviations: MDR-CT = multi-detector row computed tomography; EUS = endoscopic ultrasound.

^*Patient received neoadjuvant gemcitabine plus cisplatin.

Data are presented as no. of patients (%) unless otherwise indicated.